title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
79 Biggest Movers From Yesterday,20220608T080800,https://www.benzinga.com/news/22/06/27602286/79-biggest-movers-from-yesterday,PMVP,0.090145,Neutral,0.001836
77 Biggest Movers From Yesterday,20220601T090222,https://www.benzinga.com/news/22/06/27492435/77-biggest-movers-from-yesterday,PMVP,0.057208,Neutral,0.000168
40 Stocks Moving In Tuesday's Mid-Day Session,20220531T160405,https://www.benzinga.com/news/22/05/27478950/40-stocks-moving-in-tuesdays-mid-day-session,PMVP,0.115787,Neutral,-0.004141
"Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors - Acrivon Therapeutics  ( NASDAQ:ACRV ) ",20230622T200000,https://www.benzinga.com/pressreleases/23/06/g32975171/acrivon-therapeutics-announces-the-appointment-of-seasoned-biopharma-executive-charles-baum-m-d-ph,PMVP,0.049939,Neutral,-0.018902
70 Biggest Movers From Friday,20220531T091540,https://www.benzinga.com/news/22/05/27467950/70-biggest-movers-from-friday,PMVP,0.084702,Neutral,0.003347
